For Cancer Survivors Like Matt, Today is a New Opportunity
Today, with new treatments in the pipeline for cancer, patients and families have more hope than ever before. Learn more about Matt, as he highlights how participation in a clinical trial and innovation from America’s biopharmaceutical research companies has kept him alive.
Every Patient Has a Story
At 15 months old, Rhys was unusually tired. His pediatrician quickly figured out why: a tough combination of Type 1 diabetes and Celiac Disease. Fortunately, both can be managed with innovative medicines and diet. Today, Rhys is living the healthy, energetic childhood that every child deserves!
Medicines in Development for Osteoporosis
Advances in diagnosis and biopharmaceutical research bring hope to osteoporosis patients.
Helping patients is what drives America’s biopharmaceutical researchers and scientists
Dr. Michael Rosenblatt, chief medical officer at Merck, along with countless others in the health care ecosystem, is working tirelessly each and every day to help address the remaining unmet medical needs for patients.